Is Scynexis Inc (SCYX) overvalued? · rev $235.0K
Scynexis Inc (SCYX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page asks whether Scynexis Inc (SCYX) looks expensive on cached numbers — not a short thesis.
Latest reported SCYX revenue for 2026-06-30 was $235.0K. Net income was $7.4M. SCYX currently screens at market cap $37.7M.
SCYX currently screens at market cap $37.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SCYX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SCYX stock page for the full model, not this heading.
Not investment advice.